Open AccessA Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome
Author(s) -
Daniel O. Lee,
Ronald B. Ziman,
A. Thomas Perkins,
J. Steven Poceta,
Arthur S. Walters,
Ronald W. Barrett
Publication year - 2011
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.1074
Subject(s) - tolerability , placebo , medicine , restless legs syndrome , placebo controlled study , adverse effect , clinical global impression , randomized controlled trial , anesthesia , physical therapy , double blind , insomnia , psychiatry , alternative medicine , pathology
To evaluate the efficacy and tolerability of gabapentin enacarbil (GEn) 1200 mg or 600 mg compared with placebo in subjects with moderate-to-severe primary restless legs syndrome (RLS).